Ranbaxy Laboratories is in speaks with Ind-Swift Labs

Indian medicine manufacturer Ranbaxy Laboratories is in speaks with Ind-Swift Labs to source ingredient to produce a generic version of Pfizer Inc.’s (PFE) Lipitor blood cholesterol medicine.

Ind-Swift vice chairman N. R. Munjal stated that the firm is talking about various choices to deliver intermediate or final active pharmaceutical raw materials atorvastatin to Ranbaxy.

Ranbaxy plans to release the cholesterol medicine in the United states. at the end of November, but regulatory and producing issues at the Indian firm have late FDA authorization for the medicine.

Be Sociable, Share!
Tags: ,

Stock Market Basics For Beginners

Term Follow On Offering

Term Follow On Offering An selling of more shares after a firm has had an IPO. several times the firm is strapped for funds. Therefore they need to release ...…

Definition For Lock In Profits

Definition For Lock In Profits Realizing the profits of a position, like buying a share, through exiting at a gain. By locking in, that part of the investment is not ...…

What IS a Share?

What IS a Share? [ad name="468x15- 5 link"] share is a unit of account for various financial instruments including mutual funds, stocks, limited partnerships, and REIT's. In simple Words, stock ...…

Accelerated Vesting

Accelerated Vesting A kind of vesting which occurs at a quicker rate than the initial vesting schedule in the firm's share option plan. This enables the option ...…

The Timeframe For Obtaining Refund When Shares Not Allotted?

The Timeframe For Obtaining Refund When Shares Not Allotted? According to Securities and Exchange Board of India guidelines, the Basis of Allotment needs to be finished with fifteen days from the IPO issue end ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics